Optimal timing of influenza vaccination in patients with human immunodeficiency virus: a Markov cohort model based on serial study participant hemoagglutination inhibition titers.

作者: Gregory R. Werker , Behnam Sharif , Huiying Sun , Curtis Cooper , Nick Bansback

DOI: 10.1016/J.VACCINE.2013.11.103

关键词:

摘要: … This differs from the CDC recommendation of vaccinating as soon as the vaccine is available and is more specific than the recommendation of vaccinating “in the fall” (eg, [11]). Often a …

参考文章(34)
Andrew J. Nowalk, Julie H. Y. Tai, Rachel R. Bailey, Bruce Y. Lee, Kenneth J. Smith, Economics of influenza vaccine administration timing for children. The American Journal of Managed Care. ,vol. 16, ,(2010)
Mark J Sculpher, Karl Claxton, Andrew Briggs, Decision Modelling for Health Economic Evaluation ,(2006)
G F Rimmelzwaan, A C M Boon, A D M E Osterhaus, J C de Jong, W E P Beyer, A M Palache, Haemagglutination-inhibiting antibody to influenza virus. Developments in biologicals. ,vol. 115, pp. 63- 73 ,(2003)
A Anema, E Mills, J Montaner, JS Brownstein, C Cooper, Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis Hiv Medicine. ,vol. 9, pp. 57- 61 ,(2008) , 10.1111/J.1468-1293.2008.00515.X
Scott A Harper, Keiji Fukuda, Timothy M Uyeki, Nancy J Cox, Carolyn B Bridges, None, Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report. ,vol. 55, pp. 1- 40 ,(2004)
Natalie C. Klein, Azfar Chak, Marilyn Chengot, Diane H. Johnson, Burke A. Cunha, Fatal Case of Pneumonia Associated with Pandemic (H1N1) 2009 in HIV-Positive Patient Emerging Infectious Diseases. ,vol. 16, pp. 149- 150 ,(2010) , 10.3201/EID1601.090930
Robert J Tibshirani, Bradley Efron, An introduction to the bootstrap ,(1993)
Noelle-Angelique M. Molinari, Ismael R. Ortega-Sanchez, Mark L. Messonnier, William W. Thompson, Pascale M. Wortley, Eric Weintraub, Carolyn B. Bridges, The annual impact of seasonal influenza in the US: Measuring disease burden and costs Vaccine. ,vol. 25, pp. 5086- 5096 ,(2007) , 10.1016/J.VACCINE.2007.03.046